title: Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations.
authors.affiliation: Division of Genetics, Children's Memorial Hospital and the Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60614, USA. jcharrow@northwestern.edu
authors.forename: Joel
authors.initials: J
authors.lastname: Charrow
authors.forename: Hans C
authors.initials: HC
authors.lastname: Andersson
authors.forename: Paige
authors.initials: P
authors.lastname: Kaplan
authors.forename: Edwin H
authors.initials: EH
authors.lastname: Kolodny
authors.forename: Pramod
authors.initials: P
authors.lastname: Mistry
authors.forename: Gregory
authors.initials: G
authors.lastname: Pastores
authors.forename: Ainu
authors.initials: A
authors.lastname: Prakash-Cheng
authors.forename: Barry E
authors.initials: BE
authors.lastname: Rosenbloom
authors.forename: C Ronald
authors.initials: CR
authors.lastname: Scott
authors.forename: Rebecca S
authors.initials: RS
authors.lastname: Wappner
authors.forename: Neal J
authors.initials: NJ
authors.lastname: Weinreb
mesh_terms: D015502:Absorptiometry, Photon; D002648:Child; D004252:DNA Mutational Analysis; D005776:Gaucher Disease / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000235:genetics; D005962:Glucosylceramidase / Q000627:therapeutic use*; D006529:Hepatomegaly; D006801:Humans; D008279:Magnetic Resonance Imaging; D008991:Monitoring, Physiologic; D010808:Physical Examination; D011994:Recombinant Proteins / Q000627:therapeutic use*; D013163:Splenomegaly
chemical_list: D011994:Recombinant Proteins; D005962:Glucosylceramidase; C090568:imiglucerase